Skip to main content
padlock icon - secure page this page is secure

Endoplasmic Reticulum Stress-Triggered Autophagy and Lysosomal Dysfunction Contribute to the Cytotoxicity of Amine-Modified Silver Nanoparticles in NIH 3T3 Cells

Buy Article:

$106.34 + tax (Refund Policy)

The mechanisms underlying nanoparticle-induced toxicity have become one of the most studied topics in toxicology during the last few years. Because of their excellent antimicrobial activity, silver nanoparticles (AgNPs) are recognized as promising nanomaterials with broad applicability. However, knowledge of the impact of AgNPs on biological systems, particularly regarding their possible effects and fate in living cells remains limited. Amines are among most popular AgNPs modifying agents. In this study, we found that amine-modified AgNPs could be taken up by cells through endocytosis. The internalized AgNPs eventually accumulated in lysosomes or autophagosomes. Smaller AgNPs (SAS, ∼20 nm) were more toxic than larger AgNPs (LAS, ∼80 nm). Our results suggest that SAS caused more lysosomal swelling, arrested autophagy and cell death. The mechanisms underlying the AgNP-induced autophagy in NIH 3T3 cells could be mediated by the activation of oxidative stress and endoplasmic reticulum (ER) stress signaling pathways. AgNPs treatment could trigger the expression of ER stress and autophagy markers (IRE1 and LC3-II). However, the autophagy substrate, p62, was accumulated in AgNP-treated cells, indicating that the autophagy process was inhibited. Our results clarify the mechanism by which AgNPs induce autophagosome accumulation and reveal the effects of AgNPs on lysosomes. This study illustrates the influence of AgNPs on biological systems and may provide insights to guide the development of protective measures for biomedical applications of AgNPs.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: July 1, 2017

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more